Portland, OR, Nov. 17, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Paresthesia Treatment Market size was estimated at $5.4 billion in 2021 and is expected to hit $7.9 billion by 2031, registering a CAGR of 3.8% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/17468
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $5.4 Billion |
| Market Size in 2031 | $7.9 Billion |
| CAGR | 3.8% |
| No. of Pages in Report | 328 |
| Segments Covered | Disease Type, Treatment, Distribution Channel, and Region. |
| Drivers | Rise in the prevalence of disease such as cancer |
| Surge in the geriatric population and lack of proper nutrition in food | |
| Opportunities | Low effectiveness of medicines associated with the treatment |
| Restraints | Increase in investment in R&D activities |
Covid-19 scenario-
- Decreased production of medicines and the disrupted supply chain during the outbreak of the pandemic hampered the global paresthesia treatment market, which impacted the paresthesia treatment market negatively.
- However, as the global situation started getting back on track, the market for paresthesia treatment also restored fast.
The global paresthesia treatment market is analyzed across disease type, treatment, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on disease type, the chronic paresthesia segment contributed to more than three-fourths of the global paresthesia treatment market revenue in 2021, and is expected to dominate by 2031. The acute paresthesia segment, on the other hand, would showcase the fastest CAGR of 4.8% throughout the forecast period.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/17468
Based on treatment, the topical creams segment accounted for nearly one-third of the global paresthesia treatment market revenue in 2021, and is expected to dominate by 2031. The antivirals segment, simultaneously, would cite the fastest CAGR of 4.5% throughout the forecast period.
Based on distribution channel, the retail pharmacy segment held more than half of the global paresthesia treatment market in 2021, and is expected to dominate by 2031. The online pharmacy segment, however, would cite the fastest CAGR of 5.5% throughout the forecast period.
Based on region, the market across North America generated nearly two-fifths of the paresthesia treatment market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would showcase the fastest CAGR of 5.0% during the forecast period. The other regions studied in the report include LAMEA and Europe.
The key market players analyzed in the global paresthesia treatment market report include bbott Laboratories, Baxter International Inc., Bio-Medical Research Ltd., BostonScientific Corporation, Cipla Ltd., Cyberonics, Inc., EnteroMedics Inc., GlaxoSmithKline plc., Glenmark, AbbVie Inc., Medtronic, Merck, Nevro Corp., Omron Healthcare, Inc., Stimwave LLC, Pfizer, and Stryker Corp. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Organ-Tumor-on-a-Chip Market by Type (Lung Tumor-on-a-chip, Bone Marrow Tumor-on-a-chip, Brain Tumor-on-a-chip, Breast Tumor-on-a-chip, Urinary System Tumor-on-a-chip, Intestine Tumor-on-a-chip, and Liver Tumor-on-a-chip): Global Opportunity Analysis and Industry Forecast, 2021-2030
Advanced Drug Delivery Market by Product Type (Drug Eluting Lens, Microneedle Patch, Hydrogel Drug Delivery and Nano Carrier) and End User (Hospitals, Specialized Clinics and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts), Application (Chronic Pain, Mental Disorders, Cancer, and Others), and End User (Pharmaceutical and Research & Development Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030
Plant Tissue Culture Market by Crop Type, (Banana Plants, Floriculture Plants, Wood Producing Plants, Fruit Plants, Vegetable Plants, Ornamental Plants, Aquatic Plants and Others), Stage, (Explant Preparation and Inoculation, Multiplication And Hardening) End User, (Agriculture, Research, Gardening & Decoration And Forestry & Botanical Garden): Global Opportunity Analysis and Industry Forecast, 2021-2030
Critical Care Nutrition Market by Route of Administration (Enteral and Parenteral), Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, and Others), and Age Group (Pediatric, Adults, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
